FDA Misgivings About Reprints Would Not Make Them "False" - WLF Lawyer
Executive Summary
FDA will not be permitted to object to off-label reprints as "false and misleading" when the agency finds technical problems with an article, attorney Daniel Troy (Wiley, Rein & Fielding) asserted at an Aug. 18 Washington Legal Foundation forum on the impact of the recent WLF v. Henney off-label information dissemination ruling.